Literature DB >> 8856462

Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation.

G M Ayers1, T H Rho, J Ben-David, H R Besch, D P Zipes.   

Abstract

INTRODUCTION: We investigated whether amiodarone delivered into the pericardial sac exerted an effect on atrial and ventricular refractoriness, impulse generation, and conduction and on induced atrial fibrillation. METHODS AND
RESULTS: All animals were anesthetized with alpha-chloralose. After a sternotomy, the pericardium was opened and cradled to produce a "container" of approximately 75 mL. Part I experimental animals received amiodarone, 0.5, 1.0, or 5.0 mg/mL, dissolved in 3 mL polysorbate 80 and 5% dextrose in water (D5W) instilled into their pericardial sac for 3-hour intervals. Part II experimental animals received either 1.0 or 5.0 mg/mL of amiodarone. Control dogs received a pericardial solution of 3 mL polysorbate 80 in D5W. Pre- and postinstillation electrophysiologic studies were performed. In part I, the increase in sinus cycle length, 1:1 AV conduction, and effective refractory period (ERP) of atrium, right ventricular (RV) and left ventricular epicardium, and RV endocardium were significantly greater in animals receiving amiodarone compared with controls. Amiodarone concentrations in the tissue samples were highest in the superficial sites of the atria, sinoatrial node, and ventricular epicardial samples and lowest in the interventricular septum. Only trace concentrations of amiodarone and no desethylamiodarone were found in the blood samples. In part II, atrial ERP significantly increased in the animals receiving amiodarone, and the number of episodes of sustained atrial fibrillation that could be induced decreased.
CONCLUSIONS: Amiodarone instilled into the pericardial sac migrates transmurally to produce significant electrophysiologic effects at superficial sites and appears to suppress electrically induced atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856462     DOI: 10.1111/j.1540-8167.1996.tb00579.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

Review 1.  Intrapericardial therapy and diagnosis.

Authors:  David H Spodick
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

2.  Cardiac responses to the intrapericardial delivery of metoprolol: targeted delivery compared to intravenous administration.

Authors:  Eric S Richardson; Christopher Rolfes; Oh Sang Woo; William F Elmquist; David G Benditt; Paul A Iaizzo
Journal:  J Cardiovasc Transl Res       Date:  2011-08-30       Impact factor: 4.132

3.  Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention.

Authors:  Victor Segura-Ibarra; Francisca E Cara; Suhong Wu; David A Iruegas-Nunez; Sufen Wang; Mauro Ferrari; Arturas Ziemys; Miguel Valderrabano; Elvin Blanco
Journal:  J Control Release       Date:  2017-07-09       Impact factor: 9.776

4.  Pericardial approach for cardiac therapies: old practice with new ideas.

Authors:  Seongwook Han; Chun Hwang
Journal:  Korean Circ J       Date:  2010-10-31       Impact factor: 3.243

5.  Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine.

Authors:  Tinen L Iles; Brian Howard; Stephen Howard; Stephen Quallich; Christopher Rolfes; Eric Richardson; Hanna R Iaizzo; Paul A Iaizzo
Journal:  J Vis Exp       Date:  2016-07-07       Impact factor: 1.355

6.  Effect of epicardial application of amiodarone-releasing hydrogel on heart rate in an animal model.

Authors:  Teymuraz N Kanametov; Vladimir A Shvartz; Natalia D Oltarzhevskaya; Olga L Bockeria
Journal:  Cardiovasc Diagn Ther       Date:  2019-08

7.  Therapeutic payload delivery to the myocardium: Evolving strategies and obstacles.

Authors:  Tarek Shazly; Arianna Smith; Mark J Uline; Francis G Spinale
Journal:  JTCVS Open       Date:  2022-05-05

8.  Minimally Invasive Delivery of Hydrogel-Encapsulated Amiodarone to the Epicardium Reduces Atrial Fibrillation.

Authors:  Jose R Garcia; Peter F Campbell; Gautam Kumar; Jonathan J Langberg; Liliana Cesar; Juline N Deppen; Eric Y Shin; Neal K Bhatia; Lanfang Wang; Kai Xu; Frank Schneider; Brian Robinson; Andrés J García; Rebecca D Levit
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.